Capital Markets Webinar | 05-Nov-2024 | 07:00 | RNS |
Holding(s) in Company | 04-Nov-2024 | 07:00 | RNS |
PDMR Shareholding/Share Incentive Plan | 30-Oct-2024 | 14:58 | RNS |
Board Change Update | 29-Oct-2024 | 10:27 | RNS |
Issue of Share Options/PDMR Shareholdings | 25-Oct-2024 | 07:00 | RNS |
Cancellation of Share Premium Account | 24-Oct-2024 | 12:53 | RNS |
Holding(s) in Company | 07-Oct-2024 | 13:19 | RNS |
Block Listing Return | 07-Oct-2024 | 07:00 | RNS |
PDMR Shareholding/Share Incentive Plan | 02-Oct-2024 | 07:00 | RNS |
Board Changes | 01-Oct-2024 | 07:00 | RNS |
H1 2024 Results - Continued Performance & Growth | 17-Sep-2024 | 07:00 | RNS |
Notice of Results & Presentations | 09-Sep-2024 | 07:00 | RNS |
Appointment of Nominated Adviser and Broker | 02-Sep-2024 | 07:00 | RNS |
PDMR Shareholding/Share Incentive Plan | 30-Aug-2024 | 15:45 | RNS |
Diaceutics Launches Enhanced Rare-Disease Offering | 27-Aug-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 117.50p |
Change Today | -1.00p |
% Change | -0.84 % |
52 Week High | 134.00p |
52 Week Low | 84.50p |
Volume | 5,293 |
Shares Issued | 84.68m |
Market Cap | £99.50m |
Beta | 0.15 |
RiskGrade | 196 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:26 | 5,000 @ 117.10p |
13:19 | 268 @ 118.15p |
11:20 | 2 @ 120.00p |
11:20 | 7 @ 117.00p |
11:20 | 16 @ 117.00p |
CEO | Ryan Gerard Keeling |
CFO | Nick Roberts |
You are here: research